-
公开(公告)号:US20240327578A1
公开(公告)日:2024-10-03
申请号:US18580312
申请日:2022-07-21
发明人: Yoshinori Takashima , Akira Harada , Motofumi Osaki , Junsu Park , Daichi Yoshida , Hideo Nakagawa , Minoru Igarashi , Nobu Kato , Masanao Kamei , Kentaro Ogura
CPC分类号: C08G77/38 , C08B37/0015
摘要: Provided are a novel silicone-based polymer compound with excellent mechanical properties and a silicone-based polymer material containing the silicone-based polymer compound. The silicone-based polymer compound of the present invention is a silicone-based polymer compound (H) having a polysiloxane backbone as the main chain, wherein the polysiloxane backbone has at least one host group in a side chain, and the host group is a monovalent group formed by removing one hydrogen atom or one hydroxy group from a cyclodextrin or a cyclodextrin derivative.
-
公开(公告)号:US20240261407A1
公开(公告)日:2024-08-08
申请号:US18636093
申请日:2024-04-15
发明人: Herriot Tabuteau
IPC分类号: A61K47/02 , A61K9/00 , A61K9/20 , A61K31/4439 , A61K31/5415 , A61K45/06 , A61K47/40 , A61K47/69 , C08B37/16
CPC分类号: A61K47/02 , A61K9/0053 , A61K9/2009 , A61K31/4439 , A61K31/5415 , A61K45/06 , A61K47/40 , A61K47/6951 , C08B37/0012 , C08B37/0015
摘要: Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.
-
公开(公告)号:US20240197887A1
公开(公告)日:2024-06-20
申请号:US18366992
申请日:2023-08-08
发明人: Herriot Tabuteau
IPC分类号: A61K47/02 , A61K9/00 , A61K9/20 , A61K31/4439 , A61K31/5415 , A61K45/06 , A61K47/40 , A61K47/69 , A61P25/06 , C08B37/16
CPC分类号: A61K47/02 , A61K9/0053 , A61K9/2009 , A61K31/4439 , A61K31/5415 , A61K45/06 , A61K47/40 , A61K47/6951 , A61P25/06 , C08B37/0012 , C08B37/0015
摘要: Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.
-
公开(公告)号:US20240076415A1
公开(公告)日:2024-03-07
申请号:US18384942
申请日:2023-10-30
发明人: Chenfeng Ke , Qianming Lin
IPC分类号: C08B37/16 , A61K47/69 , A61L15/22 , A61L15/26 , A61L15/28 , A61L15/60 , A61L26/00 , A61L27/18 , A61L27/20 , A61L27/26 , A61L27/52 , B33Y10/00 , B33Y70/00 , B33Y80/00 , C08G65/332 , C08G83/00 , C08J3/075 , C08J3/24 , C08L71/02
CPC分类号: C08B37/0015 , A61K47/6951 , A61L15/225 , A61L15/26 , A61L15/28 , A61L15/60 , A61L26/0019 , A61L26/0023 , A61L26/008 , A61L27/18 , A61L27/20 , A61L27/26 , A61L27/52 , B33Y10/00 , B33Y70/00 , B33Y80/00 , C08G65/332 , C08G83/007 , C08G83/008 , C08J3/075 , C08J3/246 , C08L71/02 , A61K9/0024 , C08J2371/02 , C08L2203/02
摘要: Provided are supramolecular polypseudorotaxane hydrogel compositions and 3-D structures capable of reversible 3-D structural deformation which include (a) a solvent; (b) an at least partially linear polymer, where the polymer further comprises groups capable of covalent crosslinking between the polymers; (ii) at least one first macrocyclic ring which forms a pseudorotaxane with a polymer in the polymer network; and (iii) at least one second macrocyclic ring that does not form the pseudorotaxane. The hydrogel composition has a viscosity which allows for 3-D printing of the hydrogel to form a 3-D structure, and a storage (elastic) modulus after crosslinking that allows for the 3-D structure to undergo reversible 3-D structural deformation upon change of solvent conditions. Also provided are methods of manufacturing the compositions and 3-D structures.
-
公开(公告)号:US20240043573A1
公开(公告)日:2024-02-08
申请号:US18006926
申请日:2021-07-21
发明人: Yuya TAKAHASHI , Bunsho KURE , Tsuyoshi YAMAGUCHI , Naomi TAKENAKA , Yoshinori TAKASHIMA , Akira HARADA , Motofumi OSAKI
IPC分类号: C08B37/16
CPC分类号: C08B37/0012
摘要: The present invention provides a polymerizable unsaturated group-containing cyclodextrin derivative, which can be efficiently prepared with a higher yield and a higher purity, and which can be mass-produced.
The polymerizable unsaturated group-containing cyclodextrin derivative is represented by the following general formula (1).
(In the formula, R1 represents any one of
(A) the following general formula (2)
—R3—NH—R4 (2)
(R3 is an alkylene group having 3 to 20 carbon atoms, may be linear or branched, and may have a substituent.
R4 represents a (meth)acryloyl group or a vinyl group-containing alkyl group having 3 to 50 carbon atoms.)
(B) the following general formula (3)
—R5—NHCONH—R6 (3)
(R5 is an alkylene group having 3 to 20 carbon atoms, may be linear or branched, and may have a substituent.
R6 represents a (meth)acryloyloxyalkyl group having 4 to 50 carbon atoms or a vinyl group-containing alkyl group having 3 to 50 carbon atoms), or
(C) the following general formula (4)
—R5—OCONH—R6 (4)
(R5 and R6 are the same as those described above.)
R2 represents a hydrogen atom, an acyl group having 2 to 50 carbon atoms, or an alkyl group having 1 to 30 carbon atoms.
Rc represents a group represented by the following general formula (5).
(In the formula, R7's are the same as or different from each other, and each represent a hydrogen atom, an acyl group having 2 to 50 carbon atoms, an alkyl group having 1 to 30 carbon atoms, or —CONHR8 (R8 is an alkyl group having 1 to 20 carbon atoms), and 20% or more of R7's is any one of an acyl group having 2 to 50 carbon atoms, an alkyl group having 1 to 30 carbon atoms, or —CONHR8. x is an integer of 5 to 7))-
公开(公告)号:US20230405074A1
公开(公告)日:2023-12-21
申请号:US18184228
申请日:2023-03-15
发明人: Al Czap
IPC分类号: A61K36/736 , A61K47/69 , A61K31/19 , A61K36/185 , A61K36/889 , A61K38/47 , C08B37/16
CPC分类号: A61K36/736 , A61K47/6951 , A61K31/19 , A61K36/185 , A61K36/889 , A61K38/47 , C08B37/0015 , A61K9/48
摘要: The invention provides cyclodextrin inclusion complex delivery vehicles, in which the cyclodextrin inclusion complex is provided together with enzyme having a cyclodextrin-degrading activity capable of digesting the cyclodextrin, so that upon delivery of the vehicle to a target the enzyme is activated and releases the guest molecule from the cyclodextrin cavity. In alternative aspects, these cyclodextrin inclusion complex delivery vehicles are for example provided in the form of medicaments, food ingredients, medical food ingredients, nutritional supplement ingredients, dietary supplement ingredients, herbicides, insecticides, fungicides, animal repellents, pheromones, plant growth regulators, fragrances, fabrics or packaging materials.
-
公开(公告)号:US11840584B2
公开(公告)日:2023-12-12
申请号:US18122181
申请日:2023-03-16
申请人: Jiangnan University
发明人: Chao Qiu , Jinpeng Wang , Yao Hu , Zhengyu Jin , Qianzhu Lin , Yaoqi Tian , Aiquan Jiao , Long Chen , Zhengjun Xie , Xing Zhou
CPC分类号: C08B37/0012 , B01J27/1806
摘要: The present disclosure discloses a simple preparation method of green acid-modified cyclodextrin, belonging to the field of cyclodextrin modification. Cyclodextrin and succinic acid are mutually modified by an esterification reaction in the presence of catalyst, and acid-modified cyclodextrin with different modification degrees is obtained by controlling reaction time at a high temperature or under a microwave action. The prepared modified cyclodextrin does not involve the use of toxic and harmful reagents, the modification reaction is simple, green and controllable, and the loading capacity of the modified cyclodextrin to guest molecules is remarkably improved compared with the loading capacity of the original cyclodextrin, so that the modified cyclodextrin has great application potential in the health fields such as food, medicines, and cosmetics.
-
公开(公告)号:US11779653B2
公开(公告)日:2023-10-10
申请号:US16648204
申请日:2018-09-27
发明人: Huan Meng , Melissa J. Spencer , April D. Pyle , Courtney S. Young , Xiangsheng Liu , Ying Ji , Michael Reza Emami
CPC分类号: A61K47/6951 , A61K47/60 , A61K48/0008 , A61P35/00 , C08B37/0015 , C08G83/007
摘要: In various embodiments a polyrotaxane carrier for in vivo delivery of a nucleic acid is provided. In certain embodiments the carrier comprises: a multi-arm polyethylene glycol (PEG) backbone comprising at least three arms; at least one cyclic compound having a cavity, where an arm of said multi-arm PEG backbone is threaded into the cavity of said cyclic compound forming an inclusion complex; a bulky moiety capping the terminal of the arm(s) threaded into said cyclic compound where said moiety inhibits dethreading of the cyclodextrin from the arm(s) of said backbone; and where at least one arm of said PEG backbone is free of cyclic compounds; and where said carrier has a net positive charge.
-
公开(公告)号:US20230279158A1
公开(公告)日:2023-09-07
申请号:US17970233
申请日:2022-10-20
申请人: CycloPure, Inc.
发明人: Gokhan BARIN , Jason M. SPRUELL , Moira BROWN , Shan LI
CPC分类号: C08B31/006 , B01J20/267 , B01J20/28054 , C02F1/285 , C08L5/16 , C08B37/0012 , C08G18/7621 , C02F2303/04 , B01J20/28057 , C02F2101/36
摘要: The present disclosure relates to charge-bearing polymeric materials and methods of their use for purifying fluid samples from micropollutants, such as anionic micropollutants.
-
公开(公告)号:US11738085B2
公开(公告)日:2023-08-29
申请号:US17809151
申请日:2022-06-27
发明人: Herriot Tabuteau
IPC分类号: A61K31/5415 , A61K31/4439 , A61K9/00 , A61P25/06 , A61K47/02 , A61K47/69 , A61K47/40 , A61K9/20 , C08B37/16 , A61K45/06
CPC分类号: A61K47/02 , A61K9/0053 , A61K9/2009 , A61K31/4439 , A61K31/5415 , A61K45/06 , A61K47/40 , A61K47/6951 , A61P25/06 , C08B37/0012 , C08B37/0015
摘要: Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.
-
-
-
-
-
-
-
-
-